![]() Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy. Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis. Nutrition status and small intestinal bacterial overgrowth in patients with virus-related cirrhosis. The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis. ![]() A syndrome of cirrhosis, achlorhydria, small intestinal bacterial overgrowth, and fat malabsorption. Shindo K, Machida M, Miyakawa K, Fukumura M. Breath hydrogen excretion in patients with alcoholic liver disease-evidence of small intestinal bacterial overgrowth. Bacterial overgrowth in small intestine in patients with liver cirrhosis. ![]() Stat Med 2006 25(20):3443–3457.Ĭhesta J, Silva M, Thompson L, Del canto E, Defilippi C. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Quantifying heterogeneity in a meta-analysis. Meta-analysis of observational studies in epidemiology (MOOSE) group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Systematic review and meta-analysis: prevalence of small intestinal bacterial overgrowth in chronic liver disease. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Small intestinal bacterial overgrowth syndrome. Where is the site of bacterial translocation-small or large bowel? Transplant Proc 1996 28:2661īures J et al. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. Giannelli V, Di Gregorio V, Iebba V, et al. Small intestinal bacterial overgrowth is more often detected in cirrhosis than in healthy persons and is associated with some features of cirrhosis. Further studies are required to clarify the relationship of SIBO with hyperbilirubinemia, hypoalbuminemia, overt hepatic encephalopathy in past, esophageal varices and systemic inflammation. SIBO in cirrhosis was associated with ascites ( p < 0.001), minimal hepatic encephalopathy ( p = 0.001), bacterial translocation ( p = 0.026), spontaneous bacterial peritonitis ( p = 0.008), prolonged orocecal transit time ( p < 0.001), and was not associated with hypocoagulation. Prevalence of SIBO for decompensated cirrhosis was higher than prevalence of SIBO for compensated cirrhosis (50.5% vs. Prevalence of SIBO for cirrhosis was 40.8% (95% CI 34.8–47.1), while the prevalence of SIBO for controls was 10.7% (95% CI 5.7–19.0). 21 studies (included in total 1264 cirrhotics and 306 controls) remained for qualitative analysis and quantitative synthesis. 3 references were added after handsearching the reference lists of all the articles. Resultsġ17 references were identified by the PUBMED search. A meta-analysis of all studies was performed using a random-effects model. Studies not relating to cirrhosis or SIBO, animal studies, and non-original articles were excluded. Specific search terms were: ‘(cirrhosis) AND (SIBO OR bacterial overgrowth)’. PUBMED search (until 14 January 2018) was performed. The aim is to perform a systematic review and meta-analysis on the prevalence of SIBO in cirrhosis and on the relationship of SIBO with features of cirrhosis. Small intestinal bacterial overgrowth (SIBO) was detected in cirrhosis in many studies.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |